Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Why Choose Our Weight Loss Program
49 Phase 3 trials SYNCHRONISE-1 (in people without diabetes) and SYNCHRONISE-2 (in people with diabetes) are ongoing to assess the efficacy and durability of weight loss with 3.6 and 6 mg doses over 76 weeks (clinical trial numbers NCT06066515 and NCT06066528)
In trials with semaglutide was added on to insulin with or without metformin, severe hypoglycemia was reported in 1% of patients receiving the 14 mg tablets, 1% of patients receiving placebo, and 0% of the patients receiving the 7 mg tablets
Keep out of reach of children under 18. Do not use if allergic to any ingredients
Make sure you always apply sunscreen
Imran L
US$ 20.56
US$ 26.32
US$ 21.15
US$ 20.51
US$ 23.22
US$ 20.46
